Welcome to Store Deus Medical Official Reseller

FEMAMED 2.5 contains Letrozole, a potent aromatase inhibitor primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By effectively blocking estrogen production, FEMAMED 2.5 helps to slow or reverse the growth of estrogen-dependent tumors.

Product Overview

Letrozole works by inhibiting the aromatase enzyme, which converts androgens into estrogens. This mechanism is crucial for managing estrogen levels in patients, making FEMAMED 2.5 an essential part of therapy for individuals with breast cancer.

Usage and Dosage

The typical dosage for FEMAMED 2.5 is one tablet (2.5 mg) taken once daily. Treatment duration and dosage may vary based on individual patient response and treatment goals, so consulting with a healthcare provider is recommended.

Side Effects & Management

While FEMAMED 2.5 is generally well-tolerated, potential side effects may include hot flashes, joint pain, and fatigue. Users should monitor their health and discuss any concerns with their healthcare provider to manage these effects effectively.

Patient Safety Information

This product is intended for use under the guidance of a healthcare provider, particularly for those with a history of liver disease or other significant health concerns. Regular follow-ups are essential to assess treatment efficacy and manage any side effects.

FAQs

What benefits can I expect from using FEMAMED 2.5?
Users can expect reduced estrogen levels, which can slow or halt the progression of breast cancer.

How long does it take to see results?
Many patients may notice a positive response within weeks, but full benefits may take longer depending on individual circumstances.

Can I use FEMAMED 2.5 with other cancer treatments?
Yes, FEMAMED 2.5 can be used alongside other cancer therapies; however, it is important to consult a healthcare provider for personalized guidance.